Digital Transformation for the Pharmaceutical Industry
Pharmaceutical operations demand compliance in every step. Routeget connects batch records, quality, supply and distribution data so medicines are released on time and always traceable.
30+
clients served
$15M+
Savings Delivered
15+ yrs
Serving the Sector
20+
Projects Delivered
Pharmaceutical Industry: where the market stands today
A fact base for planning. All figures below are third-party research estimates, not Routeget data, and they differ by how each firm defines the market.
Large, regulated and growing
Ageing populations, chronic disease and biologics sustain demand, while cost and supply resilience remain priorities.
About US$1.65 to 1.68 trillion
Spherical Insights and Vision Research Reports size the global pharmaceutical market in this range for 2024.
About 5.8% to 6.5% CAGR
Publishers project steady growth through the early 2030s.
Release speed and supply assurance
Cleaner batch records and better planning speed release and protect availability for patients.
Sources: Spherical Insights; Vision Research Reports; BioSpace. Figures vary by publisher and definition; verify before external citation. Estimates retrieved October 2026 and subject to each publisher’s definitions; verify against the publisher before citing externally.
End-to-end digital transformation
Strategy, platform selection, integration and data work delivered as one programme.
Regulated-industry data models
Batch, lot, specification and change records designed for GxP-style environments.
Compliance and audit readiness
Electronic records, approvals and traceability built into daily workflows.
Laboratory and plant integration
Connections between laboratory systems, production, warehouse and finance.
Four pressures that shape pharmaceutical operations
These are the recurring problems we see when formulation, filling, packaging, serialisation and distribution operations run on disconnected systems.
Batch record review
Paper and system records are reviewed manually, slowing release.
Serialisation and traceability
Markets require unit-level codes, yet data is held by packaging vendors.
Deviations and change control
Deviations and changes are tracked outside the production system.
Cold-chain and distribution
Temperature-sensitive products need monitored, documented transport.
Capabilities built for formulation, filling, packaging, serialisation and distribution operations
Pick the area closest to your priority. Each can be delivered on its own or as part of a wider programme.
Keep controlled records for pharmaceutical products.
- Formula, specification and master-record management
- Batch records with in-process checks
- Change control and deviation workflows
- Lot genealogy from ingredient to customer
Make audits routine rather than a project.
- Electronic approvals and audit trails
- Supplier qualification and material release
- Complaint, recall and CAPA workflows
- Document and training control
Connect the lab to the plant.
- Sample, test and result tracking by lot
- Stability and retention sample management
- Equipment calibration and maintenance records
- Yield and cost by batch
Plan, ship and sell with control.
- Controlled-temperature and expiry-aware stock
- Serialisation and customer shipment records
- Tender, contract and price management
- Margin by product, market and channel
Two scenarios where connected data changes the day-to-day
These are illustrative scenarios that describe the business objective. They are not customer case studies.
Releasing batches faster
Exceptions-based review focuses quality teams on deviations rather than every page.
Business objective: shorten release without weakening control.
Managing a recall
From any lot, the team lists every shipment, customer and location.
Business objective: act within regulatory timelines.
How we approach delivery and evidence outcomes
We do not publish unverified customer figures on industry pages. This is how we make outcomes measurable in an engagement.
Baseline first
We agree the starting measures with you before design, such as batch release time, right-first-time batches and stock-out rate.
Delivery in stages
Releases are phased by site and process, so each stage is tested against real operations before the next.
Measured against your targets
Dashboards report the baseline measures from go-live, so benefit is judged on your data.
Examples of Routeget engagements can be discussed in a discovery call, subject to client approval for each reference.
Why Routeget for pharmaceutical
We bring a delivery approach built around the realities of strict GMP requirements, serialisation rules and long supply chains.
GMP and serialisation depth
We link batch, quality and serial data to products so audits, recalls and market rules are met from one record.
Integrated, not stitched together
Laboratory, production, quality, warehouse and finance share one data model, so operational and financial records reconcile.
Phased, low-disruption rollout
We plan releases around regulatory inspections, tender cycles and patent expiry to protect service levels.
Data you can act on
Analytics are designed with your operations team, so measures reflect how your plants actually run.
Related reading from the Routeget team
Perspectives on the supply chain, data and integration topics behind this industry.
Why Automating our Supply Chain is Crucial to your Business Success
Why supply chain automation matters for service levels, cost and resilience.
The Evolving Landscape of Data Modernization Engineering
Trends in data modernization engineering and how they affect enterprise platforms.
AI attracts a new generation while assisting Argentine small producers and winemakers in competing
How AI is helping small producers compete in demanding markets.
Explore adjacent industry practices
Plan your pharmaceutical digital foundation with Routeget
Book a 30-minute discovery to walk through your plants, quality labs, depots and distributors and your priorities with a Routeget industry specialist.
Your details are used only to respond to this enquiry. See our Privacy Policy.
Pharmaceutical: questions buyers ask us
How do you engage with a pharmaceutical business?
We usually start with a short discovery and a process review of one product and its batch record. From there we propose a phased scope, which can be fixed-scope for defined releases or a time-and-materials team for ongoing improvement.
Can you support GMP environments?
Our designs support controlled records, approvals and audit trails, with validation handled in line with your quality procedures.
How is serialisation handled?
Serial codes are captured at packing and linked to shipments for market-specific reporting.
Who owns the data and the configuration?
You do. The solution runs in your own environment, and configuration, data models and reports are documented and handed over so your team can maintain them.
How do you approach pricing and timelines?
Pricing and timing follow scope, including the number of products, plants and regulated markets. We share an estimate after discovery, with assumptions and exclusions stated, and we confirm timelines only after reviewing your landscape.